Kontakt

Shane Gleghorn

Partner

Read More
Kontakt

Shane Gleghorn

Partner

Read More

31. Mai 2019

Taylor Wessing announces another year of record success

In 2018/19 Taylor Wessing achieved continued UK and global revenue growth to highest levels yet. UK profit rose by 10% and profits per partner by 13%.

Taylor Wessing has announced its 2018/19 unaudited financial results, achieving a 9% increase in fee billing and an 8% increase in overall UK revenue to £156.6m, its highest level to date (£144.6m 2017/18). UK profit increased by 10% to £62.6m (£56.8m 2017/18) and in UK profit per equity partner has increased by 13%.

Global revenue grew by 13% to £339.7m (£301.5m 2017/18), the same percentage increase as last year and another record revenue figure for the firm.

UK Managing Partner, Shane Gleghorn, commented: "The results are very pleasing because we have achieved this high level of profitability and record fee income in a year that has seen a substantial increase in investment in our business. The commitment of our people to deliver successful outcomes for our clients is just fantastic and we will continue to invest in a way that enables them to do that.

We increased our fee income across our areas of sector and practice area focus with some standout performances including a surge in corporate technology deals, particularly around digital platforms. We also achieved strong growth in areas such as patents, data and cybersecurity, Private wealth, real estate and employment. Indeed, all of our core areas of legal services performed well."

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Produktsicherheit & Produkthaftung

Katie Chandler recognised in The Lawyer's Hot 100 2024

29. Januar 2024

von Shane Gleghorn und Katie Chandler

Klicken Sie hier für Details
UK

Alexandre Silberman’s portrait 'Diena' wins the Taylor Wessing Photo Portrait Prize 2023

9. November 2023

von Shane Gleghorn

Klicken Sie hier für Details
Life Sciences & Healthcare

Further recognition for our market-leading work in the life sciences sector

21. September 2023

von mehreren Autoren

Klicken Sie hier für Details